tradingkey.logo
搜索

DaVita Inc

DVA
添加自选
210.975USD
+1.295+0.62%
收盘 06/23, 16:00美东报价延迟15分钟
13.96B总市值
19.29市盈率 TTM

DaVita Inc

210.975
+1.295+0.62%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.62%

5天

+0.95%

1月

+6.27%

6月

+83.90%

今年开始到现在

+85.70%

1年

+54.74%

关键数据
211.710今开
213.820最高
858.13K成交量
19.29市盈率 TTM
13.71市盈率动
--股息TTM
1.30%换手率
209.680昨收
209.950最低
108.87M成交额
14.91市盈率静
-18.48市净率
0.00%股息率 TTM
6.33%ROA
202.69052周最高
0.97量比
936.34M净利润
66.19M总股本
10.9395每股收益TTM
0.90Beta
635.30%ROE
101.00052周最低
1.85%振幅
26.22%毛利率
13.96B总市值
2.87回报/风险
1.96%风险率

TradingKey DaVita Inc股票评分

单位: USD 更新时间: 2026-06-22

操作建议

DaVita Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗服务供应商行业排名21/76位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价193.73。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

DaVita Inc评分

相关信息

行业排名
21 / 76
全市场排名
107 / 4577
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

7°C

过冷
过热
中性

DaVita Inc亮点

亮点风险
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
估值高估
公司最新PE估值19.17,处于3年历史高位
机构减仓
最新机构持股36.02M股,环比减少8.30%
沃伦·巴菲特持仓
明星投资者沃伦·巴菲特持仓,最新持仓市值23.75M

分析师目标

根据 9 位分析师
持有
评级
193.730
目标均价
-7.61%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

DaVita Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

DaVita Inc简介

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
公司代码DVA
公司DaVita Inc
CEORodriguez (Javier J)
网址https://www.davita.com/

常见问题

DaVita Inc(DVA)的当前股价是多少?

DaVita Inc(DVA)的当前股价是 210.97。

DaVita Inc的股票代码是什么?

DaVita Inc的股票代码是DVA。

DaVita Inc股票的52周最高点是多少?

DaVita Inc股票的52周最高点是202.69。

DaVita Inc股票的52周最低点是多少?

DaVita Inc股票的52周最低点是101.00。

DaVita Inc的市值是多少?

DaVita Inc的市值是13.96B。

现在DaVita Inc(DVA)的股票是买入、持有还是卖出?

根据分析师评级,DaVita Inc(DVA)的总体评级为signal_hold,目标价格为193.73。

DaVita Inc(DVA)股票的每股收益(EPS TTM)是多少

DaVita Inc(DVA)股票的每股收益(EPS TTM)是10.06。
KeyAI